Adaptive Biotechnologies Corp Forecast, price target & analysts
Adaptive Biotechnologies Corp Target price 2025 - Analyst rating & recommendation
Adaptive Biotechnologies Corp Classifications & Recommendation:
Adaptive Biotechnologies Corp Price Target
| Target Price | $17.34 |
| Price | $14.53 |
| Potential |
19.34%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Adaptive Biotechnologies Corp 2026 .
The average Adaptive Biotechnologies Corp target price is $17.34.
This is
19.34%
register free of charge
$21.00
44.53%
register free of charge
$11.11
23.54%
register free of charge
|
|
| A rating was issued by 14 analysts: 12 Analysts recommend Adaptive Biotechnologies Corp to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Adaptive Biotechnologies Corp stock has an average upside potential 2026 of
19.34%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 178.96 | 244.15 |
| 5.10% | 36.43% | |
| EBITDA Margin | -81.03% | -20.22% |
| 26.38% | 75.05% | |
| Net Margin | -89.12% | -43.17% |
| 32.63% | 51.56% |
10 Analysts have issued a sales forecast Adaptive Biotechnologies Corp 2025 . The average Adaptive Biotechnologies Corp sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Adaptive Biotechnologies Corp EBITDA forecast 2025. The average Adaptive Biotechnologies Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Adaptive Biotechnologies Corp Analysts have issued a net profit forecast 2025. The average Adaptive Biotechnologies Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.08 | -0.69 |
| 30.77% | 36.11% | |
| P/E | negative | |
| EV/Sales | 8.82 |
10 Analysts have issued a Adaptive Biotechnologies Corp forecast for earnings per share. The average Adaptive Biotechnologies Corp EPS is
This results in the following potential growth metrics and future valuations:
Adaptive Biotechnologies Corp...
Current Adaptive Biotechnologies Corp Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Oct 15 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Oct 22 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Oct 15 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 06 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
